上海谊众(688091.SH)发预增，预计2025年度归母净利润同比增长760.18%到903.54%

Core Viewpoint - Shanghai Yizhong (688091.SH) expects a significant increase in net profit for the year 2025, projecting a range of 60 million to 70 million yuan, representing a growth of 760.18% to 903.54% compared to the previous year [1] Group 1: Financial Performance - The anticipated net profit for 2025 is between 60 million and 70 million yuan [1] - This represents a substantial increase of 760.18% to 903.54% year-on-year [1] Group 2: Key Drivers - The primary reason for the performance change is the inclusion of the company's core product, paclitaxel polymer micelles, in the national medical insurance catalog for 2025 [1] - This inclusion is expected to significantly enhance market access and the number of patients using the product, leading to a notable increase in revenue and profit compared to 2024 [1]